A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma.
Yuan J, Kashiwagi S, Reeves P, Nezivar J, Yang Y, Arrifin NH, Nguyen M, Jean-Mary G, Tong X, Uppal P, Korochkina S, Forbes B, Chen T, Righi E, Bronson R, Chen H, Orsulic S, Brauns T, Leblanc P, Scholler N, Dranoff G, Gelfand J, Poznansky MC.
Yuan J, et al. Among authors: poznansky mc.
J Hematol Oncol. 2014 Feb 24;7:15. doi: 10.1186/1756-8722-7-15.
J Hematol Oncol. 2014.
PMID: 24565018
Free PMC article.